Sen. Gayle Harrell

Public Records and Meetings/Psychology Interjurisdictional Compact; Providing an exemption from public records requirements for certain information held by the Department of Health or the Board of Psychology pursuant to the Psychology Interjurisdictional Compact; providing an exemption from public meeting requirements for certain meetings of the Psychology Interjurisdictional Compact Commission; providing for future legislative review and repeal of the exemptions; providing a statement of public necessity, etc.

Emergency Response Mapping Data; Creating the School Mapping Data Grant Program within the Department of Education; authorizing each school district to apply for funds to provide mapping data for public school buildings; authorizing a school district to use the funds to procure a vendor; requiring the entity that produces the data to provide the data to certain entities, etc.

Florida Atlantic University Men’s Basketball Team; Recognizing and celebrating the incredible accomplishments of the Florida Atlantic University men’s basketball team and the university’s commitment to both academic and athletic excellence, creating a collegiate brand that is nationally renowned, etc.

Esophageal Cancer Awareness Month ; Recognizing April 2023 as Esophageal Cancer Awareness Month in Florida, etc.

Transportation-related Facility Designations; Providing honorary designations of certain transportation facilities in specified counties; directing the Department of Transportation to erect suitable markers, etc.

Public Records/Motor Vehicle Crashes/Traffic Citations; Revising agencies to which a public records exemption for certain motor vehicle crash reports applies; revising the types of crash reports that may be made immediately available to certain radio and television stations and newspapers; providing a public records exemption for certain electronic crash data; providing an exemption from public records requirements for driver information contained in a uniform traffic citation; providing for future legislative review and repeal of the exemption; providing statements of public necessity, etc.

Department of Highway Safety and Motor Vehicles; Requiring law enforcement agencies to annually report race and ethnicity data of certain violators to the department; deleting a precondition to a requirement that the operator of a motor vehicle display proof of maintenance of security to a law enforcement officer or certain other persons; requiring that distinguishing numbers assigned to identification cards and driver licenses, respectively, have a specified minimum number of randomly generated digits beginning on a specified date; extending the date by which the department must implement a rebuilt motor vehicle inspection program; adding counties where the program must be implemented, etc.

Sexual Offenses Definitions; Defining the term “female genitals” and revising the definitions of the terms “sexual battery” and “sexual bestiality”; requiring that HIV test results performed on inmates arrested for sexual offenses involving female genital penetration be disclosed under certain circumstances, etc.

Substance Abuse Service Providers; Revising the types of expenditures for district programs and services which are eligible for state payment; requiring service provider applicants to include the names and locations of certain recovery residences in their license application; requiring service providers to record specified information in the Department of Children and Families’ Provider Licensure and Designations System after a specified date; requiring certified recovery residence administrators to demonstrate the ability to meet specified requirements; requiring service providers to return an individual’s personal effects upon the individual’s discharge, etc.

Prescription Drugs Used in the Treatment of Schizophrenia for Medicaid Recipients; Authorizing the approval of drug products or certain medication prescribed for the treatment of schizophrenia or schizotypal or delusional disorders for Medicaid recipients who have not met the step-therapy prior authorization criteria, when the drug product or certain medication meets specified criteria, etc.